Posted on

Recall of Ranitidine medication


BGIS

Recall of Ranitidine medication

The Department of Commerce and Consumer Affairs (DCCA) is reminding consumers not to use Ranitidine medication following its previous recall of October 2019.

The Food and Drug Administration (FDA) in the United States has recalled all medications manufactured with ranitidine said to have been possibly contaminated with the chemical Nnitrosodimethylamine (NDMA).

A press release said Ranitidine is commonly known by the brand name Zantac. NDMA is classified as a “probable human carcinogen”.

The Department of Commerce and Consumer Affairs has advised those who have these products to contact their doctor by phone before discontinuing use. Moreover, in light of the current coronavirus (COVID-19) pandemic, the department has urged consumers to take the affected product to the pharmacy for proper disposal.

For further information, call the Department of Commerce and Consumer Affairs at 535-7000, 535-7003, 535-7005 or [email protected] (BGIS)

 

Download the Telegram app from the App Store or Play Store and sign up for new alerts at this link.

Join Nation News on Telegram

nationnews-on-telegram

LAST NEWS